1. Home
  2. SCWO vs SER Comparison

SCWO vs SER Comparison

Compare SCWO & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 374Water Inc.

SCWO

374Water Inc.

N/A

Current Price

$2.44

Market Cap

42.3M

Sector

Utilities

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$2.74

Market Cap

42.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCWO
SER
Founded
2021
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.3M
42.0M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
SCWO
SER
Price
$2.44
$2.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
52.3K
54.5K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$215,037.00
$130,000.00
Revenue This Year
$25,798.80
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.85
N/A
Revenue Growth
N/A
132.14
52 Week Low
$0.19
$1.22
52 Week High
$3.60
$7.92

Technical Indicators

Market Signals
Indicator
SCWO
SER
Relative Strength Index (RSI) 57.67 63.48
Support Level $2.35 $1.69
Resistance Level $2.81 $3.16
Average True Range (ATR) 0.17 0.21
MACD 0.01 0.01
Stochastic Oscillator 50.82 78.75

Price Performance

Historical Comparison
SCWO
SER

About SCWO 374Water Inc.

374Water Inc is a cleantech and environmental services company developing SCWO for the destruction of organic waste streams within the municipal, federal, and industrial markets. It offers its proprietary AirSCWO technology, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy. Its AirSCWO technology is designed to effectively convert solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, including forever chemicals into inert and recoverable resources including water, minerals, and heat energy.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: